Pharmacologic Management of Portal Hypertension
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 23 (4) , 713-736
Abstract
No abstract availableKeywords
This publication has 134 references indexed in Scilit:
- Targeting the Gut–Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-BlockersAdvances in Therapy, 2013
- Renin–angiotensin–aldosterone inhibitors in the reduction of portal pressure: A systematic review and meta-analysisJournal of Hepatology, 2010
- Sildenafil Has No Effect on Portal Pressure but Lowers Arterial Pressure in Patients With Compensated CirrhosisClinical Gastroenterology and Hepatology, 2010
- Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed # †Hepatology, 2009
- Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats†Hepatology, 2007
- Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthaseHepatology, 2007
- Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic ratsJournal of Hepatology, 2007
- Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertensionJournal of Hepatology, 1994
- Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertensionJournal of Hepatology, 1990
- Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with CirrhosisNew England Journal of Medicine, 1981